[Drug treatment of oligospermia of idiopathic origin. Critical review].
Controlled studies are essential in any evaluation of the effects of treatment in cases of sterility due to oligospermia because of the important inter-individual variations in the sperm count and in the spontaneous pregnancy rate. The various hormonal and non-hormonal treatments for idiopathic oligospermia are described with special emphasis on the results of double-blind studies. Future prospects for the treatment of male sterility by in vitro fertilisation are then discussed.
D000728:Androgens / Q000627:therapeutic use; D006063:Chorionic Gonadotropin / Q000627:therapeutic use; D002996:Clomiphene / Q000627:therapeutic use; D005307:Fertilization in Vitro; D005640:Follicle Stimulating Hormone / Q000627:therapeutic use; D005544:Forecasting; D007987:Gonadotropin-Releasing Hormone / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007610:Kallikreins / Q000627:therapeutic use; D008297:Male; D009845:Oligospermia / Q000188:drug therapy* / Q000503:physiopathology; D010431:Pentoxifylline / Q000627:therapeutic use; D013629:Tamoxifen / Q000627:therapeutic use
D000728:Androgens; D006063:Chorionic Gonadotropin; D013629:Tamoxifen; D002996:Clomiphene; D007987:Gonadotropin-Releasing Hormone; D005640:Follicle Stimulating Hormone; D007610:Kallikreins; D010431:Pentoxifylline
Traitement médicamenteux de l'oligospermie d'origine idiopathique. Revue critique.